• Equity investment by H&S in Jatcorp to strengthen strategic partnership
• Agreement conditional on H&S meeting product purchase milestones of at least A$8 million in FY25 and A$25 million across FY25 and FY26
• Up to 4,000,000 ordinary shares may be issued to H&S if sales targets are met

Jatcorp Limited (ASX: JAT), a leading Australian health and wellness consumer goods company, has signed a sales incentive agreement with strategic partner and Tier 1 retailer, H&S International (HK) Co. Limited ('H&S International' or 'H&S') to drive sales of Jatcorp's Moroka® brand in Mainland China. The agreement is designed to strengthen the partnership between Jatcorp and H&S, incentivise and reward H&S for its commitment to Moroka® and help grow the brand into a leading household wellness brand. Under the agreement, Jatcorp has conditionally agreed to progressively issue up to 4,000,000 ordinary shares to H&S, subject to the achievement of specified product purchase milestones. H&S operates over 200 cross-border e-commerce (CBEC) stores across China's leading platforms and is a long-term strategic partner and major distributor for Jatcorp. In FY24, H&S generated A$3.35 million in sales of Moroka® products and played a pivotal role in making Moroka® the fastest-growing lactoferrin brand in China's CBEC channel, securing the #3 ranking on Tmall by revenue.

If H&S purchases at least A$8 million worth of Moroka® products in FY25 and A$25 million across FY25 and FY26, Jatcorp will issue up to 4,000,000 ordinary shares to H&S, representing up to 4.80% of Jatcorp's current issued capital.

The agreement is expected to deliver a material step change in Moroka® sales in Mainland China and help grow the brand into a leading household wellness brand.